These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24980780)

  • 1. Haemoglobinopathies in Europe: health & migration policy perspectives.
    Aguilar Martinez P; Angastiniotis M; Eleftheriou A; Gulbis B; Mañú Pereira Mdel M; Petrova-Benedict R; Corrons JL
    Orphanet J Rare Dis; 2014 Jul; 9():97. PubMed ID: 24980780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and control of haemoglobinopathies.
    Angastiniotis M; Modell B; Englezos P; Boulyjenkov V
    Bull World Health Organ; 1995; 73(3):375-86. PubMed ID: 7614670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Blood Disorders Survey in the Sultanate of Oman.
    Al-Riyami A; Ebrahim GJ
    J Trop Pediatr; 2003 Jul; 49 Suppl 1():i1-20. PubMed ID: 12934793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn screening for haemoglobinopathies: the Brussels experience.
    Gulbis B; Tshilolo L; Cotton F; Lin C; Vertongen F
    J Med Screen; 1999; 6(1):11-5. PubMed ID: 10321364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of hemoglobinopathies in Brussels: a necessity?].
    Gulbis B; Cotton F; Hansen V; Ferster A; Toppet M; Cochaux P; Parma J; Vassart G; Fondu P; Vertongen F
    Rev Med Brux; 2001 Jun; 22(3):133-40. PubMed ID: 11488080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Universal neonatal screening for sickle cell disease and other haemoglobinopathies in Ferrara, Italy.
    Ballardini E; Tarocco A; Marsella M; Bernardoni R; Carandina G; Melandri C; Guerra G; Patella A; Zucchelli M; Ferlini A; Bigoni S; Ravani A; Garani G; Borgna-Pignatti C
    Blood Transfus; 2013 Apr; 11(2):245-9. PubMed ID: 23058858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of haemoglobinopathies in various populations - the impact of immigration.
    Henderson S; Timbs A; McCarthy J; Gallienne A; Van Mourik M; Masters G; May A; Khalil MS; Schuh A; Old J
    Clin Biochem; 2009 Dec; 42(18):1745-56. PubMed ID: 19497317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A national registry of haemoglobinopathies in Greece: deducted demographics, trends in mortality and affected births.
    Voskaridou E; Ladis V; Kattamis A; Hassapopoulou E; Economou M; Kourakli A; Maragkos K; Kontogianni K; Lafioniatis S; Vrettou E; Koutsouka F; Papadakis A; Mihos A; Eftihiadis E; Farmaki K; Papageorgiou O; Tapaki G; Maili P; Theohari M; Drosou M; Kartasis Z; Aggelaki M; Basileiadi A; Adamopoulos I; Lafiatis I; Galanopoulos A; Xanthopoulidis G; Dimitriadou E; Mprimi A; Stamatopoulou M; Haile ED; Tsironi M; Anastasiadis A; Kalmanti M; Papadopoulou M; Panori E; Dimoxenou P; Tsirka A; Georgakopoulos D; Drandrakis P; Dionisopoulou D; Ntalamaga A; Davros I; Karagiorga M;
    Ann Hematol; 2012 Sep; 91(9):1451-8. PubMed ID: 22526366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of migrations on the health services for rare diseases in Europe: the example of haemoglobin disorders.
    Angastiniotis M; Vives Corrons JL; Soteriades ES; Eleftheriou A
    ScientificWorldJournal; 2013; 2013():727905. PubMed ID: 23576907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemoglobinopathies and newborn haemoglobinopathy screening in Germany.
    Dickerhoff R; Genzel-Boroviczeny O; Kohne E
    J Clin Pathol; 2009 Jan; 62(1):34. PubMed ID: 19103856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tackling rare diseases at European level: why do we need a harmonized framework?
    Taruscio D; Trama A; Stefanov R
    Folia Med (Plovdiv); 2007; 49(1-2):59-67. PubMed ID: 18018471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neonatal screening for hemoglobinopathies in the Brussels region].
    Tshilolo L; Gulbis B; Barlow P; Damis E; Denis-Song R; Ferster A; Haumont D; Vanderpas JB; Pardou A; Schwers J; Vokaer A; Vertongen F
    Rev Med Brux; 1997 Apr; 18(2):70-3. PubMed ID: 9221465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immigration and changes in the epidemiology of hemoglobin disorders in Italy : an emerging public health burden.
    Cataldo F
    Ital J Pediatr; 2012 Jul; 38():32. PubMed ID: 22823956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemoglobinopathies and patients with foreign names].
    Lilleholt K; Hallberg MH; Hagve TA
    Tidsskr Nor Laegeforen; 2005 May; 125(9):1164-7. PubMed ID: 15880152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance for Sickle Cell Disease - Sickle Cell Data Collection Program, Two States, 2004-2018.
    Snyder AB; Lakshmanan S; Hulihan MM; Paulukonis ST; Zhou M; Horiuchi SS; Abe K; Pope SN; Schieve LA
    MMWR Surveill Summ; 2022 Oct; 71(9):1-18. PubMed ID: 36201430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of haemoglobinopathies in Sicily: the impact of screening and prenatal diagnosis.
    Giambona A; Damiani G; Vinciguerra M; Jakil C; Cannata M; Cassarà F; Picciotto F; Schillaci G; Cigna V; Renda D; Leto F; Passarello C; Maggio A
    Int J Clin Pract; 2015 Oct; 69(10):1129-38. PubMed ID: 25727926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral healthcare systems in the extended European union.
    Widström E; Eaton KA
    Oral Health Prev Dent; 2004; 2(3):155-94. PubMed ID: 15641621
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.